cilostazol has been researched along with Critical Illness in 5 studies
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol is a phosphodiesterase III inhibitor with a firm evidence base for use in intermittent claudication." | 5.35 | Cilostazol may improve outcome in critical limb ischemia. ( Davies, AH; Franklin, IJ; Shalhoub, J, 2009) |
| " Conservative treatment included: (a) weight-adjusted bemiparin plus six hours/day intravenous iloprost for 28 days, (b) aspirin (100 mg/day) plus cilostazol (100 mg twice/day) after discharge, and (c) strict recommendations/monitoring for smoking cessation." | 3.85 | Conservative treatment of patients with thromboangiitis obliterans or cannabis-associated arteritis presenting with critical lower limb ischaemia. ( Anastasiadou, C; Galyfos, G; Geropapas, G; Giannakakis, S; Kastrisios, G; Kerasidis, S; Maltezos, C; Papacharalampous, G; Papapetrou, A; Sachmpazidis, I, 2017) |
| "Cilostazol treatment also increased freedom from target lesion revascularization (RR, 1." | 2.72 | Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization. ( Desai, K; Han, B; Kuziez, L; Yan, Y; Zayed, MA, 2021) |
| "Cilostazol is a phosphodiesterase III inhibitor with a firm evidence base for use in intermittent claudication." | 1.35 | Cilostazol may improve outcome in critical limb ischemia. ( Davies, AH; Franklin, IJ; Shalhoub, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, K | 1 |
| Han, B | 1 |
| Kuziez, L | 1 |
| Yan, Y | 1 |
| Zayed, MA | 1 |
| Galyfos, G | 1 |
| Kerasidis, S | 1 |
| Kastrisios, G | 1 |
| Giannakakis, S | 1 |
| Sachmpazidis, I | 1 |
| Anastasiadou, C | 1 |
| Geropapas, G | 1 |
| Papapetrou, A | 1 |
| Papacharalampous, G | 1 |
| Maltezos, C | 1 |
| Furuyama, T | 1 |
| Onohara, T | 1 |
| Yamashita, S | 1 |
| Yoshiga, R | 1 |
| Yoshiya, K | 1 |
| Inoue, K | 1 |
| Morisaki, K | 1 |
| Kyuragi, R | 1 |
| Matsumoto, T | 1 |
| Maehara, Y | 1 |
| Spiliopoulos, S | 1 |
| Shalhoub, J | 1 |
| Davies, AH | 1 |
| Franklin, IJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study of the Efficacy and Safety of Cilostazol in the Prevention of Ischemic Vascular Events in Diabetic Patients With Symptomatic Peripheral Artery Disease.[NCT02983214] | Phase 4 | 826 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for cilostazol and Critical Illness
| Article | Year |
|---|---|
Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Cilostazol; Critical Illness; Endovascular Procedures | 2021 |
Antiplatelet therapy in critical limb ischemia: update on clopidogrel and cilostazol.
Topics: Cilostazol; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; End | 2014 |
3 other studies available for cilostazol and Critical Illness
| Article | Year |
|---|---|
Conservative treatment of patients with thromboangiitis obliterans or cannabis-associated arteritis presenting with critical lower limb ischaemia.
Topics: Adult; Amputation, Surgical; Ankle Brachial Index; Anticoagulants; Arteritis; Aspirin; Cardiovascula | 2017 |
Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Cilostazol; Critical Illness; Debridement; Disease-Fr | 2018 |
Cilostazol may improve outcome in critical limb ischemia.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amputation, Surgical; Cilostazol; Critical Illness; F | 2009 |